Drugs create balancing act for patients with non-small cell lung cancer

(Johns Hopkins Medicine) Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy researchers identified a correlation between multisystem immune-related adverse events and improved rates of survival. This new information will be helpful in discussing with patients the spectrum of immune side effects that may occur from immunotherapy and the implications for their future.